A study by Oxford called Com-COV that compared mixed two-doses schedules of Pfizer and AstraZeneca COVID-19 vaccines found that both mixed schedules produced better immune responses than two doses of AstraZeneca vaccine. An AstraZeneca shot followed by Pfizer four weeks apart produced the best T-cell responses, and also a higher antibody response than Pfizer followed by AstraZeneca.